The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis

Blood

Volumn 105, Issue 4, 2005, Pages 1699-1705

  Xu, Mingjiang ^b   Bruno, Edward ^b   Chao, Joseph ^b   Ni, Hongyu ^b   Lindgren, Valerie ^b   Nunez, Rafael ^b   Mahmud, Nadim ^b   Finazzi, Guido ^b   Fruchtman, Steven M ^b   Popat, Uday ^b   Liu, Enli ^b   Prchal, Josef T ^b   Rondelli, Damiano ^b   Barosi, Giovanni ^b   Hoffman, Ronald ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; FIBRINOGEN RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW REPOPULATING CELL; CELL CLONING; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LEUKEMIC TRANSFORMATION; MALE; MALIGNANT TRANSFORMATION; MOUSE; MOUSE STRAIN; MYELOID METAPLASIA; NONHUMAN; PHENOTYPE; POPULATION DYNAMICS; PRIORITY JOURNAL; SCID MOUSE; STEM CELL MOBILIZATION; TRANSCRIPTION REGULATION;

EID: 13544254271     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-06-2485     Document Type: Article

References (40)

1. Hoffman R, Ravandi F. Idiopathic myelofibrosis. In: Hoffman R, Benz Jr E, Shattil S, Furie B, Cohen HJ, Silberstein L, McGlave P, eds. Hematology: Basic Principles and Practice. 4th ed. New York, NY: Churchill Livingstone; 2004;1255-1276.
2. Barosi G. Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol. 1999;17:2954-2970.
3. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342:1255-1265.
4. Thiele J, Pierre R, Imbert M, et al. Chronic idiopathic myelofibrosis. In: Jaffe ES, Harris N, Stan N, Vardiman JW, eds. World Health Organization of Tumors of Hematopoietic and Lymphoid Tissues. Washington, DC: IARC Press; 2001:35-38.
5. LeBousse-Kerdiles MC, Martyré MC. Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis. Ann Hematol. 1999;78: 437-44.
6. Martyré MC, Romquin N, LeBousse-Verdiles MC, et al. Transforming growth factor-α and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br J Haematol. 1994; 88:9-16.
7. Kimura A, Katoh O, Kuramoto A. Effect of platelet derived growth factor, epidermal growth factor and transforming growth factor-α on the growth of human marrow fibroblasts. Br J Haematol. 1988; 69:9-12.
8. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL. Physiological migration of hematopoietic stem and progenitor cells. Science. 2001;294:1933-1936.
9. Abkowitz JL, Robinson AE, Kale S, Long MW, Chen J. Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood. 2003;102:1249-1253.
10. Van Epps DE, Bender J, Lee W, et al. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood. Blood Cells. 1994;20:411-23.
11. Bender JG, Unverzagt K, Walker DE, et al. Phenotypic analysis and characterization of CD344-cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. Clin Immunol Immunopathol. 1994;70:10-18.
12. + cells in myelofibrosis with myeloid metaplasia. Blood. 2001;98:3249-3255.
13. Carlo-Stella C, Cazzola M, Gasner A, et al. Effects of recombinant α and γ interferons on in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-MK, BFU-E and CFU-GM) from patients with myelofibrosis with myeloid metaplasia. Blood. 1987;70:1014-1019.
14. Juvonen E. Megakaryocyte colony formation in chronic myeloid leukemia and myelofibrosis. Leuk Res. 1988;12:751-758.
15. Han ZC, Briere J, Nedellec G, et al. Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis. Eur J Haematol. 1988;40:130-135.
16. Hoffman R, Baker KR, Prchal JT. The polycythemias. In: Hoffman R, Benz Jr E, Shattil S, Furie B, Cohen HJ, Silberstein L, McGlave P, eds. Hematology: Basic Principles and Practice. 4th ed. New York, NY: Churchill Livingslone; 2004;1209-1245.
17. Popat U, Frost A, Liu E, et al. Myelofibrosis is frequently seen in patients with primary pulmonary hypertension and is associated with polyclonal hematopoiesis and normal CD34 count [abstract]. Blood. 2003;102:919a.
18. Bradford GB, Williams B, Rossi R, Bertoncello I. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol. 1997;25:445-455.
19. Xu MJ, Tsuji K, Ueda T, et al. Stimulation of mouse and human primitive hematopoiesis by murine embryonic aorta-gonad-mesonephros-derived stromal cell lines. Blood. 1998;92:2032-2040.
20. Milhem M, Mahmud N, Lavelle D, et al. Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A. Blood. 2004;103:4102-4110.
21. Tournoy KG, Depraetere S, Meuleman P, Leroux-Roels G, Pauwels RA. Murine IL-2 receptor beta chain blockade improves human leukocyte engraftment in SCID mice. Eur J Immunol. 1998;28:3221-3230.
22. Liu E, Jelinek J, Pastore YD, et al. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood. 2003;101:3294-3301.
23. Coyle T, Najfeld V. Translocation (3;21) in Philadelphia chromosome-positive chronic myelogenous leukemia prior to the onset of blast crisis. American Journal of Hematology. 1988;27:56-59.
24. Mitelman F, ed. ISCN: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger, 1995
25. + cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood. 1997;88: 1189-1196.
26. + cells. Blood. 1994;84:2930-2939.
27. Uchida N, He D, Friera AM, et al. The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood. 1997;89:465-472.
28. Xiao M, Dooley DC. Cellular and molecular aspects of human CD344+ CD38- precursors: analysis of a primitive hematopoietic population. Leuk Lymphoma. 2000;38:489-497.
29. Sutherland H, Blair A, Vercauteren S, Zapf R. Detection and clinical significance of human acute myeloid leukaemia progenitors capable of longterm proliferation in vitro. Br J Haematol. 2001;114:296-306.
30. Berer A, Jager E, Sagaster V, et al. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes. Ann Hematol. 2003;82:271-277.
31. - cells home specifically to the bone marrow of NOD/LtSZ scid/scid mice but show different kinetics in expansion. J Immunol. 2001;167:3692-3698.
32. van der Loo JC, Hanenberg H, Cooper RJ, et al. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells. Blood. 1998;92:2556-2570.
33. Thanopoulou E, Cashman J, Kakagianne T, et al. Engraftment of NOD/SCID-β2 microglobulin null mice with multi-lineage neoplastic cells from patients with myelodysplastic syndrome. Blood. 2004;103:4285-4293.
34. Wang JCY, Lapidot T, Cashman JD, et al. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood. 1998;91:2406-2414.
35. Rombouts WJC, Martens ACM, Ploemacher RE. Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model. Leukemia. 2000;14:889-897.
36. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine. 1997;3:730-737.
37. Lock RB, Liem N, Farnsworth ML, et al. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse. Blood. 2002;99:4100-4108.
38. Auewarakul CU, Promsuwicha O, U-Pratya Y, Pattanapanyasat K, Issaragrisil S. Immunophenotypic profile of adult acute myeloid leukemia (AML): analysis of 267 cases in Thailand. Asian Pac J Allergy Immunol. 2003;21:153-160.
39. Raspadori D, Damiani D, Lenoci M, et al. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia. 2001;15:1161-1164.
40. Bilhou-Nabera C, Brigaudeau C, Clay D, et al. Does cytogenetic mosaicism in CD34+CD38low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis?[letter] Blood. 2003;102:1551-1552.